FDA approves Eli Lilly’s obesity medication for obstructive sleep apnea - ABC News
- FDA approves Eli Lilly’s obesity medication for obstructive sleep apnea ABC News
- FDA approves Zepbound® (tirzepatide) as the first and only prescription medicine for moderate-to-severe obstructive sleep apnea in adults with obesity Investors | Eli Lilly and Company
- Lilly's weight-loss treatment Zepbound becomes first FDA-approved drug for sleep apnea Reuters
- The First Sleep Apnea Drug Is Here TIME